Showing 38,221 - 38,240 results of 55,387 for search '(( 5 ((ng decrease) OR (we decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 1.21s Refine Results
  1. 38221

    Table_10_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  2. 38222

    Table_6_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  3. 38223

    Table_3_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  4. 38224

    Table_4_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  5. 38225

    Table_2_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  6. 38226

    Table_1_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  7. 38227

    Table_8_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

    Published 2024
    “…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”
  8. 38228

    The Effects of Financial Education on Impulsive Decision Making by William B. DeHart (3151785)

    Published 2016
    “…Both groups completed a delay-discounting task for $100 during the first two weeks (Time 1) of the semester as well as during the last two weeks (Time 2) of the semester. …”
  9. 38229

    Light micrographs of muscle implantation histologic sections. by Li-Xia Hu (460219)

    Published 2013
    “…Similar inflammatory reaction was observed on the LDPE composite side (A). After 4 weeks of implantation, the number of heterophil granulocytes decreased sharply, and lymphocytes were seldom. …”
  10. 38230

    Effect of MT on apoptosis in experimental groups. by Eduardo Peña-Mercado (13257039)

    Published 2022
    “…(a). Scale bar: 100 μm (a), (c) and (e). Magnification: Scale bar: 50 μm (b), (d) and (f). …”
  11. 38231
  12. 38232

    MSCs migration assay. by Fang-Yuan Wei (624669)

    Published 2014
    “…<p>(<b>A</b>) The migrated MSCs on the exterior of the insert in UG (left) were remarkably increased compared with UAG (middle) and CG (right) at ×100 magnification. …”
  13. 38233

    Representative images of HBO-treated MSCs. by Jennifer Schulze (2502799)

    Published 2017
    “…All pictures are presented at a 200-fold magnification. Scale bar: 100 μm.</p>…”
  14. 38234

    Enrichment of native-contacts between Score_set and our method. by Qingzhen Hou (2742370)

    Published 2016
    “…The ordering of the targets is the same as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155251#pone.0155251.g003" target="_blank">Fig 3</a>. …”
  15. 38235

    The effect of asymmetric movement support on muscle activity during Lokomat guided gait in able-bodied individuals - Fig 1 by Sylvana Weiland (5334758)

    Published 2018
    “…<p><b>EMG profiles for Medial Gastrocnemius (MG) when guidance offered to the contralateral leg (CL) increases (A) or decreases (B) while guidance of the ipsilateral leg (IL) was held constant at 30% (A) or 100% (B).…”
  16. 38236

    Mexican warning label system. by Claudia Calderon (266352)

    Published 2024
    “…<div><p>In 2020, Mexico’s Congress mandated front-of-package warning labels (FOPWL) and two cautionary legends; one of which for non-nutritive sweeteners (NNS) with a statement “Contains NNS. Avoid in children”. …”
  17. 38237

    S1 Dataset - by Claudia Calderon (266352)

    Published 2024
    “…<div><p>In 2020, Mexico’s Congress mandated front-of-package warning labels (FOPWL) and two cautionary legends; one of which for non-nutritive sweeteners (NNS) with a statement “Contains NNS. Avoid in children”. …”
  18. 38238

    DKT promoted the repair of the mucosal barrier and nutrient absorption functions. by Peilin Li (586356)

    Published 2023
    “…<p><b>(A)</b> The plasma DAO level in the control, MTX, DKT-MTX, and DKT groups. …”
  19. 38239

    Images with FOPWL by time of data collection. by Claudia Calderon (266352)

    Published 2024
    “…<div><p>In 2020, Mexico’s Congress mandated front-of-package warning labels (FOPWL) and two cautionary legends; one of which for non-nutritive sweeteners (NNS) with a statement “Contains NNS. Avoid in children”. …”
  20. 38240

    Attenuation of IL-1β-induced MMP-3 mRNA expression in fibroblasts transfected with ATF-2 siRNA. by Nanako Kitanaka (3350285)

    Published 2019
    “…<p>(<b>a</b>) In the cells transfected with ATF-2 and scrambled siRNAs, t-ATF-2 and β-actin were detected by western blotting. …”